ERBA Diagnostics Acquires the Calbiotech Group

ERBA Diagnostics Mannheim acquire Calbiotech group of companies 

Mannheim, Germany , 21st April 2017 ... ERBA Diagnostics Mannheim, a leading global player in the in-vitro diagnostics market, has acquired Calbiotech Inc, a USA based specialist in immunoassay development and manufacturing; Calbiotech Veterinary Diagnostics Inc, and Moduline Systems Inc. 

Financial details were not disclosed. 

ERBA Diagnostics Mannheim, with operations across Europe, USA, Russia and Asia, specialise in the development of reliable, innovative and accessible medical diagnostic solutions. The company has a comprehensive portfolio of products across a range of fields including clinical chemistry, immunology, haematology, coagulation, critical care, urine analysis, diabetes monitoring, microbiology and molecular diagnostics. 

Calbiotech Inc, based in California, USA, specialise in immunoassay development and manufacturing, with a comprehensive range of ELISA and CLIA assays for human and animal research, including specific assays for autoimmune disorders, cancer and infectious diseases. The company has over 200 products which are distributed to over 60 countries globally. 

Calbiotech Veterinary Inc, based in California is a specialised manufacturer of veterinary diagnostics and has secured a number of significant contracts in the recent past 

Moduline Systems is a manufacture of high precision liquid dispensing systems including microplate-dispensing and vial-filling equipment that continues to grow and offers versatility to IVD manufactures. 

Mr. Suresh Vazirani, Chairman and Managing Director of ERBA Diagnostics Mannheim, said: “Calbiotech Inc and Dr. Noori Barka have developed an excellent range of immunoassay products that will complement our growing range of diagnostic products. Their expertise in Immunoassay will allow Erba to strengthen our position in this high growth market and integrate their strong R&D programme to further enhance the product development strategy of the ERBA Diagnostics Mannheim group.” 

Dr. Noori Barka, CEO and President of Calbiotech Inc, Calbiotech Veterinary Inc and Microplate Dispensers Inc, said: “We’re are excited to join the growing Erba Mannheim group and enjoy the synergies of being part of a larger organisation. We found a strong strategic and cultural fit with Erba Mannheim and are eager to realise the potential of the combined companies. The strength of the ERBA brand will support our growing sales activities while enabling Calbiotech to access a wider range of global markets for our products. The acquisition will also bring synergies with ERBA’s R&D and work to accelerate the development of our novel and innovative products”